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Canine Oral Malignant Melanoma 
Adam C. Eiler, DVM * 
Kimberly R. Cox, DVM ** 
Neoplasia is an all too common find-
ing in domestic animals. The oropharyngeal 
cavity is a common site for the development 
of tumors , particularly in dogs. One such tu-
mor is oral malignant melanoma which 
occurs with some frequency in dogs but is 
rare in cats.! Hence, the following shall fo-
cus on canine malignant melanoma. 
Case Study 
"Capricorn," a nine year old spayed female 
cocker spaniel, was first presented in Novem-
ber 1989 for a dental prophylaxis. The owner 
reported no health problems at the time of 
presentation. During induction of anesthe-
sia, a mass was detected in the oral cavity. 
The mass was darkly pigmented and ap-
proximately 1 cm in diameter. It was 
attached via a thin 1 mm diameter pedicle 
to the lower right gingiva lateral to the third 
premolar and 5 mm ventral to the gum line. 
The mass was causing no obvious discom-
fort; however, the owner elected to have it 
surgically removed after completing the den-
tal prophylactic procedure. 
Based primarily on gross appearance, the 
primary differential was oral malignant 
melanoma. Therefore, prior to removal, 
neither a biopsy nor needle aspirate were 
performed. Thoracic radiographs were not 
taken to evaluate the extent of underlying 
bone involvement or distant metastasis. 
Due to the small attachment area and 
location within the mouth the mass was 
removed with approximately 2 mm margins, 
leaving the mandible intact. The mass was 
then submitted to the Iowa State University 
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Veterinary Diagnostic Laboratory for histo-
logic examination, confirming a diagnosis of 
oral malignant melanoma. Surgical clear-
ance at the margins was incomplete. The 
owner was notified of the findings and given 
a guarded prognosis for long-term survival 
due to the possibility oflocal recurrence and 
distant metastasis. 
"Capricorn" died three years following the 
initial diagnosis of oral malignant mela-
noma. Necropsy detected neoplasia of the 
liver with no apparent local recurrence of the 
oral malignant melanoma. The owner 
declined further evaluation of the neoplas-
tic liver. 
Incidence and Prevalence 
The oropharyngeal cavity is a prominent site 
for tumor development. The oral cavity is the 
fourth most common site of neoplasia in the 
dog. 2 Approximately 6.6% of all canine 
benign and malignant neoplasms occur in 
the oral cavity, most often originating from 
the buccal mucosa, tongue, periodontium, 
mandible, maxilla, and lips.2 The gingiva, 
particularly covering the molars, is the most 
common site for oral malignant melanoma 
development.3 Tumors of the oral cavity, 
regardless of tumor site, are frequently ma-
lignant and represent approximately 5.3% 
of all canine malignant tumors.1 
Malignant melanoma is the most common 
canine malignant oral neoplasm. A retrospec-
tive study reported the incidence in a defined 
canine population to be 20.4 cases per every 
100,000 dogs per year.4 It is 2.5 times more 
frequent in dogs than cats.1 Breeds report-
edly predisposed to tumor development 
include cocker spaniels, golden retrievers, 
Labrador retrievers and breeds with darkly 
pigmented mucosa.2,5 In one study, dachs-
hunds and beagles were at a significantly 
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lower risk at developing oral malignant 
melanoma.6 Malignant melanoma occurs 
most frequently in older male dogs, aging 
10.1 to 11.5 years.2,6 Based on the reported 
incidence and signalment, oral malignant 
melanoma is a likely cause of "Capricorn's" 
tumor. 
Clinical Signs 
As is the case with many diseases, the clini-
cal signs of oral malignant melanoma at the 
time of presentation are variable and non-
pathognomonic. Some of the more commonly 
reported signs are persistent or recurrent 
oral hemorrhage, oral pain or a reluctance 
to chew.2 Additional signs include displace-
ment or loss of teeth, halitosis, excessive 
salivation, facial deformity, dysphagia, ex-
cessive licking, and psychogenic 
polydipsia.2,3 Often the only clinical sign re-
ported by the owner is the presence of a mass 
in the oral cavity causing no apparent 
problems, as was the case with "Capricorn." 
Although none of the aforementioned clini-
cal signs are themselves diagnostic, each is 
strongly suggestive of an abnormality involv-
ing the oral cavity and requires further 
investigation. 
Diagnosis 
While not the only oral tumor in dogs, ma-
lignant melanoma is the most common. 
Other differential diagnoses include squa-
mous cell carcinoma, fibrosarcoma, and 
epulides.2 It is impossible to rely on gross 
appearance alone to obtain a definitive 
diagnosis as these tumors may all look 
similar. Oral malignant melanomas range 
from amelanotic to heavily pigmented; how-
ever, most veterinarians associate melanoma 
with the pigmented form, which aids in 
diagnosis.2 
Several routine procedures are recom-
mended to assist in obtaining a diagnosis. A 
complete blood count, serum biochemical 
analysis, and urinalysis are important to 
determine overall patient health.2 In addi-
tion, initial evaluation of an oral mass should 
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include measurement of the tumor size, pal-
pation of regional lymph nodes, and a fine 
needle aspirate and cytologic examination of 
any enlarged lymph nodes.2 
Radiographs of the skull and thorax are 
important to assess the extent of local tu-
mor invasion and distant metastasis. Skull 
radiographs should be evaluated for abnor-
malities associated with the mass such as 
bone lysis or new bone production. The most 
useful views are open mouth dorsoventral 
or intraoral views ofthe mandible and max-
illa, and oblique lateral projections of the 
mandible (to visualize each hemimandible 
individually). Standard right and left lateral 
and dorsoventral views of the thorax are 
useful to evaluate the lung fields for meta-
static tumor development.2 
When available, computed axial tomogra-
phy or magnetic resonance imaging are 
useful in defining the area and extent of neo-
plastic involvement.2 However, these are not 
as frequently done due to the expense and 
lack of availability. 
By far, the most reliable means of diagno-
sis and differentiation of tumor type is 
histologic examination of a biopsy sample or 
fine needle aspirate.2 The diagnostic, micro-
scopic feature of oral malignant melanoma 
is the presence of melanocytes (as melano-
mas appear to develop from melanocytes in 
the oral epithelium).7 Histologic identifica-
tion also relies upon cell shape and nuclear 
position.5 Melanomas are usually composed 
of intra epithelial nests of polyhedral epithe-
lial-like cells that contain abundant granular 
cytoplasm, large hyperchromatic or vesicu-
lar round nucleoli, and are arranged in 
irregular lobules separated by strands of 
collagen.5 The histologic examination allows 
for differentiating oral malignant melanoma 
from other oral tumors. Without histologic 
examination, only a presumptive diagnosis 
can be made. 
Treatment 
The methods of treating oral malignan"t 
melanoma are numerous. The traditional 
forms of treatment include radical surgical 
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resection, radiation therapy, cryosurgery, 
chemotherapy, and hyperthermia. 8 The 
choice of treatment method encompasses the 
desires of the owner, capabilities of the clinic, 
expense and cosmetic results. 
Ofthe traditional forms, early radical sur-
gical excision remains the foundation of 
therapy for most benign and malignant oral 
tumors.2 Hemimandibulectomy or hemi-
maxillectomy are often the procedure of 
choice. Resection of the tumor requires a 
minimum 1 cm margin of healthy tissue to 
decrease the likelihood of local recurrence.2 
Management, however, of oral malignant 
melanoma is complicated by the close asso-
ciation with bone and the lack of mobile soft 
tissues within the mouth. This leads to a 
difficulty in achieving complete excision of 
the tumor.3 Closure is limited by the amount 
of labial mucosa available.9 
In general, radical surgical resection is 
tolerated well by most dogs and has few post-
surgical complications. The most common 
postoperative complications are anemia and 
suture line dehiscence. Other complications 
include drooping of the tongue, sublingual 
edema, and mandibular drift.9 
Other forms of therapy are less success-
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ful. The response to radiation therapy is poor 
for oral malignant melanoma. Hyperthermia 
alone is ineffective and is used primarily to 
complement radiation therapy. Chemo-
therapy is usually ineffective. Cryosurgery 
is often used only as a palliative measure 
for nonresectable tumors.2 Although ineffec-
tual alone, the above have prolonged 
remission time and survival when used as 
adjuvant therapy with radical surgery.5 
A possible alternative treatment to tradi-
tional forms is the use of local, sustained 
release chemotherapy by use ofintralesional 
cisplatin implants.8 The implant is an inject-
able viscous gel composed of a protein carrier 
matrix, a vasoactive modifier (epinephrine) 
and a chemotherapeutic drug (cisplatin). 
This treatment modality enhances the con-
centration of the active drug in the tumor 
while minimizing adverse systemic effects. 
In one study, 70% of dogs with melanoma 
had a 50% decrease in tumor volume with 
50% obtaining complete remission following 
an average of two treatments. Systemic toxi-
cosis was minimal and renal insufficiency 
was not evident; however, local necrosis at 
the treatment site developed in 17 of20 dogs. 
The results of this study are encouraging 
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and warrant further research. 
Despite the recommendation for radical 
surgical excision, conservative excision is 
often the treatment chosen. Treatment by 
radical surgical excision results in longer 
remissions and survival times than does con-
servative excision.5 Surprisingly, "Capricorn" 
did well with conservative excision and 
incomplete surgical clearance. Fortunately, 
local tumor recurrence was not evident. Tu-
mors that do reoccur are often not 
successfully managed by additional surgery 
or radiation.3 Consequently, radical excision 
is still recommended to remove the entire 
tumor initially. 
Progression 
The progression of tumor development can 
be surprisingly fast. Oral malignant mela-
noma begins in the oral epithelium and is 
characterized by rapid growth, local inva-
siveness and early metastasis.7 At the time 
of diagnosis, 57% of dogs have detectable 
bone involvement and 14% have detectable 
pulmonary metastasis.4 Lymph node me-
tastasis occurs in 57% to 74% of dogs while 
distant metastasis occurs in 47% to 67% of 
dogs.4 The above explains the necessity for 
early aggressive treatment iflong-term sur-
vival is expected. 
Prognosis 
Clinical staging of oral tumors is a means of 
determining disease progression and ulti-
mately prognosis. Clinical staging of the 
patient is based on several categorizes: size 
and degree of primary tumor involvement, 
regional lymph node involvement and evi-
dence of distant metastasis. 
In general, a guarded to poor prognosis is 
invariably assigned to cases of oral malig-
nant melanoma. The poor prognosis is the 
result of the debilitation from local infiltra-
tive disease or systemic metastasis.8 
Post-surgical recurrence and distant me-
tastasis are common in oral malignant 
melanoma.7 Several studies have deter-
mined the average survival time to range 
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from 3 to 9 months following radical surgery 
with few surviving greater than 1 year.3,9 
Without surgery the survival time decreased 
to an average of2 months.9 Understandably, 
with such short survival times a guarded to 
poor prognosis is appropriate for "Capricorn". 
Conclusion 
Oral malignant melanoma is a relatively 
common finding for the small animal prac-
titioner. The signalment and clinical signs 
presented are guidelines to aid in diagnosis. 
Diagnosis relies upon physical examination, 
skull radiographs, and microscopic exami-
nation ofthe tumor. To obtain the best results 
for prolonged survival and improved qual-
ity of life, early radical surgical excision is 
recommended. Poor survival time supports 
the need for further research in discovering 
an improved treatment modality with more 
acceptable results. V 
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